EUVIMEDEUVIMED entdecken
Open Access · CC BY 3.0

Biological Activity of Lenalidomide and Its Underlying Therapeutic Effects in Multiple Myeloma

Roberta Martiniani, Valentina Di Loreto, Chiara Di Sano, Alessandra Lombardo, Anna Marina Liberati

Advances in Hematology · 2012 · 2012 · 1-11

DOI: 10.1155/2012/842945 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advances in Hematology, 2012. Verfasst von Roberta Martiniani und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncohematology, University of Perugia, Santa Maria Hospital, 05100 Terni, Italy. Die Arbeit wurde bisher 55-mal zitiert (Crossref) und nennt 96 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lenalidomide is a synthetic compound derived by modifying the chemical structure of thalidomide. It belongs to the second generation of immunomodulatory drugs (IMiDs) and possesses pleiotropic properties. Even if lenalidomide has been shown to be active in the treatment of several hematologic malignancies, this review article is mostly focalized on its mode of action in multiple myeloma. The present paper is about the direct and indirect antitumor effects of lenalidomide on malignant plasmacells, bone marrow microenvironment, bone resorption and host’s immune response. The molecular mechanisms and targets of lenalidomide remain largely unknown, but recent evidence shows cereblon (CRBN) as a possible mediator of its therapeutical effects.

Autor:innen und Institutionen

  • Department of Oncohematology, University of Perugia, Santa Maria Hospital, 05100 Terni, Italy.

Zitieren

APA

Martiniani, R., Di Loreto, V., Di Sano, C., Lombardo, A., & Liberati, A. M. (2012). Biological Activity of Lenalidomide and Its Underlying Therapeutic Effects in Multiple Myeloma. Advances in Hematology, 2012, 1-11. https://doi.org/10.1155/2012/842945

Vancouver

Martiniani R, Di Loreto V, Di Sano C, Lombardo A, Liberati AM. Biological Activity of Lenalidomide and Its Underlying Therapeutic Effects in Multiple Myeloma. Advances in Hematology. 2012;2012:1-11. doi:10.1155/2012/842945

BibTeX
@article{Martiniani2012,
  author = {Martiniani, Roberta and Di Loreto, Valentina and Di Sano, Chiara and Lombardo, Alessandra and Liberati, Anna Marina},
  title = {Biological Activity of Lenalidomide and Its Underlying Therapeutic Effects in Multiple Myeloma},
  journal = {Advances in Hematology},
  year = {2012},
  volume = {2012},
  pages = {1--11},
  doi = {10.1155/2012/842945}
}
Kostenlos starten →